The story
Founded by Eckert & Ziegler Group in 2019.1
PTP on Frankfurt Stock Exchange

Logo: pentixapharm.com3
Pentixapharm is a joint-stock company registered in Germany, part of Pentixapharm Holding AG.1 Its website says: “Pentixapharm is a radiopharmaceutical development company founded in 2019, with its headquarters in Würzburg, Germany. It is committed to develop the innovative theranostic pair PentixaFor and PentixaTher, two small peptide-based radiopharmaceuticals that specifically target the CXCR4-receptor.”3 It was founded by Eckert & Ziegler Group.1 Its chief executive is Hakim Bouterfa.1 It employed 80 people.1 Its shares trade on Frankfurt Stock Exchange under the symbol PTP.1
Price unavailable
Last updated Oct 21, 2026.
Pentixapharm is part of a group headed by Pentixapharm Holding AG. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0). Each entity in the chart links to its source.
Founded by Eckert & Ziegler Group in 2019.1
Who has led Pentixapharm, and when. Pick a name to see everywhere that person has worked.
Ownership links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); each one cites its LEI record.
The numbers on this page point here. Each one links to the record it came from.